Source: Annual Congress 2010 - Immune responses for the diagnosis of tuberculosis
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
C. Chee, K. W. KhinMar, S. H. Gan, T. Barkham, Y. T. Wang (Singapore, Singapore). Repeat testing of ELISpot-positive TB contacts at 32 to 36 months post-exposure. Eur Respir J 2010; 36: Suppl. 54, 271

Member's Comments

No comment yet.

Related content which might interest you: Outcomes of 6-9-12 months’ bedaquiline-containing regimens in MDR/XDR TB after 24 months follow up Source: International Congress 2018 – Drug-resistant tuberculosis Year: 2018 Secondary TB risk in contacts over 35 years with IGRA positive latent tuberculosis Source: Annual Congress 2010 - Interferon-gamma releases assays (IGRAs) for the diagnosis of tuberculosis: what is the role? Year: 2010 When do we extend the treatment of tuberculosis (TB) more than 6 months? Source: Annual Congress 2007 - Clinical tuberculosis Year: 2007 Tolerance to rifampicine (RIF) 4 months vs. isoniazid (INH) 6 months for latent tuberculosis infection (LTBI) Source: Annual Congress 2008 - Clinical epidemiology of tuberculosis Year: 2008 Follow-up of TB cases failing or defaulting the first TB treatment, in Romania Source: Annual Congress 2012 - Non-tuberculous and tuberculous mycobacterial infections: from epidemiology to clinical findings Year: 2012 The tuberculin skin test in 11-12 year-old children 5 years after BCG vaccination Source: Eur Respir J 2006; 28: Suppl. 50, 20s Year: 2006 Predictors of delayed smear conversion after 2 months of tuberculosis treatment Source: Annual Congress 2012 - Tuberculous and non-tuberculous mycobacterial infections: epidemiology I Year: 2012 Tuberculosis in children – 12 years follow up bacteriologically confirmed diagnosis Source: Annual Congress 2006 - Diagnosis and treatment of tuberculosis Year: 2006 Treatment of latent tuberculosis infection with 6 months isoniazid therapy in pediatric population Source: Eur Respir J 2005; 26: Suppl. 49, 624s Year: 2005 A comparison of on-site versus remote physician follow up of directly observed preventive treatment (DOPT) for latent tuberculosis infection (LTBI) on completion rates Source: Annual Congress 2012 - Tuberculous and non-tuberculous mycobacterial infections: epidemiology II Year: 2012 Evaluation of new smear positive tuberculosis patients 5 years after initiation of treatment under a DOTS programme Source: Annual Congress 2010 - Tuberculosis epidemiology Year: 2010 Who misses the 12 week evaluation in tuberculosis contact screening? Source: Annual Congress 2010 - Tuberculosis control Year: 2010 Specificity of mycobacterial population susceptibility to TB drugs in patients aged 13-17 Source: Eur Respir J 2002; 20: Suppl. 38, 360s Year: 2002 The relevance of smear exam at two month of re-treatment for further evolution of the relapsed TB cases Source: Annual Congress 2008 - Epidemiological and clinical aspects of tuberculosis control Year: 2008 QFT-GIT vs TST in diagnosis of latent tuberculosis infection (LTBI) in Poland Source: Annual Congress 2011 - Tuberculin skin tests, interferon-gamma release assays and beyond Year: 2011 Treatment of latent tuberculosis with 12 weeks isoniazid/rifapentine in clinical practice Source: Eur Respir J, 53 (2) 1801128; 10.1183/13993003.01128-2018 Year: 2019 Tuberculin skin test size and risk of tuberculosis: A 12-year follow-up of contacts of TB cases Source: Annual Congress 2011 - Tuberculin skin tests, interferon-gamma release assays and beyond Year: 2011 Comparison of tuberculin skin test (TST) and QuantiFERON-TB-Gold in Tube (QFT) in the diagnosis of latent tuberculosis infection (LTBI) in a prospective community study of contacts of tuberculosis (TB) Source: Annual Congress 2010 - What is new in the diagnosis of tuberculosis? Year: 2010 Mode of delivery and lung function of 16-19 year olds born at less than 29 weeks gestation Source: Virtual Congress 2020 – Respiratory disorders in neonatal and paediatric intensive care units: ventilation and chronic conditions Year: 2020 Late Breaking Abstract - Short 12-month regimen with intravenous linezolid for pre-XDR TB: treatment outcomes and 24 months follow-up results Source: International Congress 2019 – Tuberculosis: treatment and management Year: 2019